TY  - JOUR
AU  - Bacsur, Péter
AU  - Wetwittayakhlang, Panu
AU  - Resál, Tamás
AU  - Földi, Emese
AU  - Vasas, Béla
AU  - Farkas, Bernadett
AU  - Rutka, Mariann
AU  - Bessissow, Talat
AU  - Afif, Waqqas
AU  - Bálint, Anita
AU  - Fábián, Anna
AU  - Bor, Renáta
AU  - Szepes, Zoltán
AU  - Farkas, Klaudia
AU  - Lakatos, Péter László
AU  - Molnár, Tamás
TI  - Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system
JF  - THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
J2  - THER ADV GASTROENTER
VL  - 17
PY  - 2024
PG  - 11
SN  - 1756-283X
DO  - 10.1177/17562848241239606
UR  - https://m2.mtmt.hu/api/publication/34752035
ID  - 34752035
N1  - First published online March 21, 2024
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Magyar, Dániel
AU  - Fábián, Anna
AU  - Vasas, Béla
AU  - Nacsev, Krisztián
AU  - Dubravcsik, Zsolt
AU  - Bősze, Zsófia
AU  - Tóth, Tibor
AU  - Bacsur, Péter
AU  - Bálint, Anita
AU  - Farkas, Klaudia
AU  - Molnár, Tamás
AU  - Resál, Tamás
AU  - Bor, Renáta
AU  - Szepes, Zoltán
TI  - Szűrő kolonoszkópos vizsgálatok hatékonyságának és biztonságosságának értékelése a Szegedi Tudományegyetemen és a Bács-Kiskun Vármegyei Oktatókórházban 2019 és 2022 között [Analysis of efficacy and safety of colonoscopic screening program at the University of Szeged and the Bács-Kiskun County Teaching Hospital between 2019 and 2022]
JF  - ORVOSI HETILAP
J2  - ORV HETIL
VL  - 165
PY  - 2024
IS  - 6
SP  - 221
EP  - 231
PG  - 11
SN  - 0030-6002
DO  - 10.1556/650.2024.32979
UR  - https://m2.mtmt.hu/api/publication/34635367
ID  - 34635367
N1  - Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szeged, Hungary            
            Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szent-Györgyi Albert Klinikai Központ, Belgyógyászati Klinika, Szeged, Hungary            
            Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szent-Györgyi Albert Klinikai Központ, Patológiai Intézet, Szeged, Hungary            
            Bács-Kiskun Vármegyei Oktatókórház, Kecskemét, Hungary            
            Kálvária sgt. 57., 6725, Szeged, Hungary            
            Export Date: 17 March 2024            
            CODEN: ORHEA            
            Chemicals/CAS: midazolam, 59467-70-8, 59467-96-8
LA  - Hungarian
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Resál, Tamás
AU  - Bacsur, Péter
AU  - Pápista, M
AU  - Kata, D
AU  - Farkas, Bernadett
AU  - Bálint, Anita
AU  - Fábián, Anna
AU  - Bor, Renáta
AU  - Szepes, Zoltán
AU  - Farkas, Klaudia
AU  - Molnár, Tamás
TI  - P938 Effectiveness and safety of switching from original infliximab to GP1111 biosimilar in inflammatory bowel diseases – prospective, cohort study
JF  - JOURNAL OF CROHNS & COLITIS
J2  - J CROHNS COLITIS
VL  - 18
PY  - 2024
IS  - Supplement_1
SP  - i1706
EP  - i1707
PG  - 2
SN  - 1873-9946
DO  - 10.1093/ecco-jcc/jjad212.1068
UR  - https://m2.mtmt.hu/api/publication/34546005
ID  - 34546005
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Bacsur, Péter
AU  - Resál, Tamás
AU  - Farkas, Bernadett
AU  - Sarlós, P
AU  - Iliás, Á
AU  - Kata, Diána
AU  - Bálint, Anita
AU  - Fábián, Anna
AU  - Bor, Renáta
AU  - Szepes, Zoltán
AU  - Molnár, Tamás
AU  - Farkas, Klaudia
TI  - P674 Real-world experiences of switching to subcutaneous formulation in IBD patients on maintenance vedolizumab treatment
JF  - JOURNAL OF CROHNS & COLITIS
J2  - J CROHNS COLITIS
VL  - 18
PY  - 2024
IS  - Supplement_1
SP  - i1279
EP  - i1280
PG  - 2
SN  - 1873-9946
DO  - 10.1093/ecco-jcc/jjad212.0804
UR  - https://m2.mtmt.hu/api/publication/34538619
ID  - 34538619
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Ivány, Emese
AU  - Farkas, Bernadett
AU  - Resál, Tamás
AU  - Bacsur, Péter
AU  - Bálint, Anita
AU  - Farkas, Klaudia
AU  - Molnár, Tamás
TI  - P560 The impact of reactive point-of-care drug level measurement on the medium-term course of inflammatory bowel disease
JF  - JOURNAL OF CROHNS & COLITIS
J2  - J CROHNS COLITIS
VL  - 18
PY  - 2024
IS  - Supplement_1
SP  - i1097
EP  - i1097
PG  - 1
SN  - 1873-9946
DO  - 10.1093/ecco-jcc/jjad212.0690
UR  - https://m2.mtmt.hu/api/publication/34538612
ID  - 34538612
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Bacsur, Péter
AU  - Wetwittayakhlang, P
AU  - Resál, Tamás
AU  - Farkas, Bernadett
AU  - Rutka, Mariann
AU  - Bessissow, T
AU  - Afif, W
AU  - Bálint, Anita
AU  - Fábián, Anna
AU  - Bor, Renáta
AU  - Szepes, Zoltán
AU  - Farkas, Klaudia
AU  - Lakatos, Péter László
AU  - Molnár, Tamás
TI  - P356 Long-term outcome of UC patients in clinical remission with different level of mucosal activity: real world, retrospective, multicontinental study
JF  - JOURNAL OF CROHNS & COLITIS
J2  - J CROHNS COLITIS
VL  - 18
PY  - 2024
IS  - Supplement_1
SP  - i759
EP  - i760
PG  - 2
SN  - 1873-9946
DO  - 10.1093/ecco-jcc/jjad212.0486
UR  - https://m2.mtmt.hu/api/publication/34533257
ID  - 34533257
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Resál, Tamás
AU  - Bacsur, Péter
AU  - Keresztes, Csilla
AU  - Bálint, Anita
AU  - Bor, Renáta
AU  - Fábián, Anna
AU  - Farkas, Bernadett
AU  - Katsanos, Kostas
AU  - Michalopoylos, George
AU  - Ribaldone, Davide Giuseppe
AU  - Attauabi, Mohamed
AU  - Zhao, Mirabella
AU  - Barak, Hadar Amir
AU  - Yanai, Henit
AU  - Bezzio, Cristina
AU  - Rispo, Antonio
AU  - Castiglione, Fabiana
AU  - Bar-Gil Shitrit, Ariella
AU  - Pugliese, Daniela
AU  - Armuzzi, Alessandro
AU  - Savarino, Edoardo Vincenzo
AU  - Kolar, Martin
AU  - Lukáš, Milan
AU  - Chashkova, Elena
AU  - Filip, Rafał
AU  - Rozieres, Aurore
AU  - Nancey, Stéphane
AU  - Krznarić, Željko
AU  - Schäfer, Eszter
AU  - Szamosi, A
AU  - Sarlós, Patrícia
AU  - Franko, Matej
AU  - Drobne, David
AU  - Knyazev, Oleg V
AU  - Kagramanova, Anna V
AU  - Limdi, Jimmy
AU  - Wetwittayakhlang, Panu
AU  - Lakatos, Péter László
AU  - Maharshak, Nitsan
AU  - Bannon, Lian
AU  - Nyári, Tibor András
AU  - Szepes, Zoltán
AU  - Farkas, Klaudia
AU  - Molnár, Tamás
TI  - Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis. A Retrospective Worldwide Multicenter Collaborative Study
TS  - A Retrospective Worldwide Multicenter Collaborative Study
JF  - INFLAMMATORY BOWEL DISEASES
J2  - INFLAMM BOWEL DIS
VL  - In press
PY  - 2024
PG  - 12
SN  - 1078-0998
DO  - 10.1093/ibd/izad135
UR  - https://m2.mtmt.hu/api/publication/34089134
ID  - 34089134
AB  - Tofacitinib (TFB) appears to be effective in the treatment of ulcerative colitis (UC); however, available real-world studies are limited by cohort size. TFB could be an option in the treatment of acute severe ulcerative colitis (ASUC). We aimed to investigate efficacy and safety of TFB in moderate-to-severe colitis and ASUC.This retrospective, international cohort study enrolling UC patients with ≥6-week follow-up period was conducted from February 1 to July 31, 2022. Indications were categorized as ASUC and chronic activity (CA). Baseline demographic and clinical data were obtained. Steroid-free remission (SFR), colectomy, and safety data were analyzed.A total of 391 UC patients (median age 38 [interquartile range, 28-47] years; follow-up period 26 [interquartile range, 14-52] weeks) were included. A total of 27.1% received TFB in ASUC. SFR rates were 23.7% (ASUC: 26.0%, CA: 22.8%) at week 12 and 41.1% (ASUC: 34.2%, CA: 43.5%) at week 52. The baseline partial Mayo score (odds ratio [OR], 0.850; P = .006) was negatively associated with week 12 SFR, while biologic-naïve patients (OR, 2.078; P = .04) more likely achieved week 52 SFR. The colectomy rate at week 52 was higher in ASUC group (17.6% vs 5.7%; P < .001) and decreased with age (OR, 0.94; P = .013). A total of 67 adverse events were reported, and 17.9% resulted in cessation of TFB. One case of thromboembolic event was reported.TFB is effective in both studied indications. TFB treatment resulted in high rates of SFR in the short and long terms. Higher baseline disease activity and previous biological therapies decreased efficacy. No new adverse event signals were found.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Farkas, Klaudia
AU  - Resál, Tamás
AU  - Bacsur, Péter
AU  - Farkas, Bernadett
AU  - Bálint, Anita
AU  - Fábián, Anna
AU  - Bor, Renáta
AU  - A., Shitrit
AU  - D., Pugliese
AU  - D., Drobne
AU  - H., Yanai
AU  - T., Szamosi
AU  - M., Lukas
AU  - A., Kagramanova P.L. Lakatos
AU  - N., Maharshak
AU  - G., Michalopoulos
AU  - S., Nancey
AU  - Z., Krznaric
AU  - Szepes, Zoltán
AU  - Molnár, Tamás
TI  - Real-life effectiveness of tofacitinib in two indications in ulcerative colitis: a retrospective worldwide, multicenter, collaborative study
JF  - UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
J2  - UEG JOURNAL
VL  - 11
PY  - 2023
IS  - S8
SP  - 202
EP  - 202
PG  - 1
SN  - 2050-6406
UR  - https://m2.mtmt.hu/api/publication/34593738
ID  - 34593738
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Farkas, Bernadett
AU  - Ivány, E
AU  - Bálint, Anita
AU  - Fábián, Anna
AU  - Szepes, Zoltán
AU  - Bacsur, Péter
AU  - Resál, Tamás
AU  - Farkas, Klaudia
AU  - Molnár, Tamás
TI  - A GYULLADÁSOS BÉLBETEGEK JÁRÓBETEG-ELLÁTÁSA A KLINIKAI GYAKORLATBAN
JF  - MAGYAR BELORVOSI ARCHIVUM
J2  - MBA
VL  - 76
PY  - 2023
IS  - 5-6
SP  - 305
EP  - 305
PG  - 1
SN  - 0133-5464
UR  - https://m2.mtmt.hu/api/publication/34559993
ID  - 34559993
LA  - Hungarian
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Bor, Renáta
AU  - Vasas, Béla
AU  - Fábián, Anna
AU  - Szűcs, Mónika
AU  - Bősze, Zsófia
AU  - Bálint, Anita
AU  - Rutka, Mariann
AU  - Farkas, Klaudia
AU  - Tóth, Tibor
AU  - Resál, Tamás
AU  - Bacsur, Péter
AU  - Molnár, Tamás
AU  - Szepes, Zoltán
TI  - Risk Factors and Interpretation of Inconclusive Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology in the Diagnosis of Solid Pancreatic Lesions
JF  - DIAGNOSTICS
J2  - DIAGNOSTICS
VL  - 13
PY  - 2023
IS  - 17
PG  - 16
SN  - 2075-4418
DO  - 10.3390/diagnostics13172841
UR  - https://m2.mtmt.hu/api/publication/34129891
ID  - 34129891
AB  - Background: The inconclusive cytological findings of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) remain a major clinical challenge and often lead to treatment delays. Methods: Patients who had undergone EUS-FNA sampling for solid pancreas lesions between 2014 and 2021 were retrospectively enrolled. The “atypical” and “non-diagnostic” categories of the Papanicolaou Society of Cytopathology System were considered inconclusive and the “negative for malignancy” category of malignancy was suspected clinically. We determined the frequency and predictors of inconclusive cytological finding. Results: A total of 473 first EUS-FNA samples were included, of which 108 cases (22.83%) were inconclusive. Significant increases in the odds of inconclusive cytological findings were observed for lesions with a benign final diagnosis (OR 11.20; 95% CI 6.56–19.54, p < 0.001) as well as with the use of 25 G FNA needles (OR 2.12; 95% CI 1.09–4.01, p = 0.023) compared to 22 G needles. Furthermore, the use of a single EUS-FNA technique compared to the combined use of slow-pull and standard suction techniques (OR 1.70; 95% CI 1.06–2.70, p = 0.027) and less than three punctures per procedure led to an elevation in the risk of inconclusive cytology (OR 2.49; 95% CI 1.49–4.14, p < 0.001). Risk reduction in inconclusive cytology findings was observed in lesions between 2–4 cm (OR 0.40; 95% CI 0.23–0.68, p = 0.001) and >4 cm (OR 0.16; 95% CI 0.08–0.31, p < 0.001) compared to lesions ≤2 cm. Conclusions: The more than two punctures per EUS-FNA sampling with larger-diameter needle (19 G or 22 G) using the slow-pull and standard suction techniques in combination may decrease the probability of inconclusive cytological findings.
LA  - English
DB  - MTMT
ER  -